Atlas FDA

HeartWare HVAD System

FDA premarket approval P100047/S115 · decided 2018-07-26

Approval details

PMA number
P100047
Supplement
S115
Supplement type
Normal 180 Day Track No User Fee
Supplement reason
Postapproval Study Protocol
Trade name
HeartWare HVAD System
Generic name
Ventricular (assist) bypass
Applicant
Medtronic
Date received
2017-10-30
Decision date
2018-07-26
Days to decision
269 days
Decision code
APPR
Product code
DSQ
Advisory committee
Cardiovascular
Expedited review
No
Location
Mounds View, MN
Statement
This device is indicated for hemodynamic support in patients with advanced, refractory leftventricular heart failure; either as a bridge to cardiac transplantation (BTT), myocardial recovery, or as destination therapy (DT) in patients for whom subsequent transplantation is not planned. We are pleased to inform you that the PMA supplement is approved.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
Trexon™ Monofilament Synthetic Absorbable Suture (K253530)Medtronic2026-05-28
Affinity Pixie™ Arterial Filter with Balance™ Biosurface; Affinity® Pediatric Arterial Blood Filter (K251744)Medtronic2026-01-16
Sphere-9Dx Diagnostic Catheter (AFR-00009) (K233433)Medtronic2024-08-07
MYOtherm XP Cardioplegia Delivery System with Cortiva BioActive Surface, MYOtherm XP Cardioplegia Delivery System Uncoated (K240190)Medtronic2024-02-23
CD Horizon Spinal System (K223494)Medtronic2023-01-23
SelectSite C304 Deflectable Catheter System, C315 Delivery System (K223178)Medtronic2022-11-08
Attain Command + SureValve Delivery System, Attain Select II + SureValve delivery system (K222873)Medtronic2022-11-07
CD Horizon™ Spinal System (K221244)Medtronic2022-05-25